Indian-made COVID vaccines will save the world

China and US no match when it comes to manufacturing capacity and safety

Avatar
20201211 vials AstraZeneca Covishield.JPG

Vials of AstraZeneca's Covishield inside a lab at Serum Institute of India in Pune, pictured on Nov. 30: the COVID-19 vaccine is of particular value in developing nations. © Reuters

Sreeram Chaulia is a professor and dean at the Jindal School of International Affairs in Sonipat, India. He is author of "Trumped: Emerging Powers in a Post-American World."

With vaccines from America's Pfizer and China's state-owned pharma group Sinopharm receiving their first overseas authorizations, the frantic race to produce and distribute the most-sought-after medicine in recent memory is on.

Sponsored Content

About Sponsored ContentThis content was commissioned by Nikkei's Global Business Bureau.